These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 8946354)
1. Effect of 6-aminonicotinamide on the pentose phosphate pathway: 31P NMR and tumor growth delay studies. Koutcher JA; Alfieri AA; Matei C; Meyer KL; Street JC; Martin DS Magn Reson Med; 1996 Dec; 36(6):887-92. PubMed ID: 8946354 [TBL] [Abstract][Full Text] [Related]
2. In vivo detection by 31P NMR of pentose phosphate pathway block secondary to biochemical modulation. Mahmood U; Street JC; Matei C; Ballon D; Martin DS; Koutcher JA NMR Biomed; 1996 May; 9(3):114-20. PubMed ID: 8892397 [TBL] [Abstract][Full Text] [Related]
3. Quantitation of metabolic and radiobiological effects of 6-aminonicotinamide in RIF-1 tumor cells in vitro. Street JC; Alfieri AA; Koutcher JA Cancer Res; 1997 Sep; 57(18):3956-62. PubMed ID: 9307279 [TBL] [Abstract][Full Text] [Related]
4. Influence of 6-aminonicotinamide (6AN) on Leishmania promastigotes evaluated by metabolomics: Beyond the pentose phosphate pathway. Almugadam SH; Trentini A; Maritati M; Contini C; Rugna G; Bellini T; Manfrinato MC; Dallocchio F; Hanau S Chem Biol Interact; 2018 Oct; 294():167-177. PubMed ID: 30170107 [TBL] [Abstract][Full Text] [Related]
5. Effect of 6-aminonicotinamide on pentose cycle activity in isolated hepatocytes. Carmona A; Freedland RA Int J Biochem; 1990; 22(6):595-9. PubMed ID: 2143150 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of chemotherapy and radiation enhancement and 31P NMR spectral changes induced by biochemical modulation. Koutcher JA; Alfieri AA; Tsai JC; Matei C; Stolfi RL; Ballon D; Martin DS Cancer Invest; 1997; 15(2):111-20. PubMed ID: 9095206 [TBL] [Abstract][Full Text] [Related]
7. Effect of 6-aminonicotinamide on renin release in isolated rat kidney: possible role for the pentose pathway. Rostand SG; Work J Am J Physiol; 1985 Aug; 249(2 Pt 2):F213-9. PubMed ID: 3161339 [TBL] [Abstract][Full Text] [Related]
8. Metabolism via the pentose phosphate pathway in rat pheochromocytoma PC12 cells: effects of nerve growth factor and 6-aminonicotinamide. Davis LH; Kauffman FC Neurochem Res; 1987 Jun; 12(6):521-7. PubMed ID: 2955240 [TBL] [Abstract][Full Text] [Related]
9. 6-Aminonicotinamide inhibition of the pentose phosphate pathway in rat neocortex. Tyson RL; Perron J; Sutherland GR Neuroreport; 2000 Jun; 11(9):1845-8. PubMed ID: 10884030 [TBL] [Abstract][Full Text] [Related]
10. Radiation enhancement by biochemical modulation and 5-fluorouracil. Koutcher JA; Alfieri AA; Thaler H; Matei C; Martin DS Int J Radiat Oncol Biol Phys; 1997 Dec; 39(5):1145-52. PubMed ID: 9392557 [TBL] [Abstract][Full Text] [Related]
11. 13C and 31P NMR investigation of effect of 6-aminonicotinamide on metabolism of RIF-1 tumor cells in vitro. Street JC; Mahmood U; Ballon D; Alfieri AA; Koutcher JA J Biol Chem; 1996 Feb; 271(8):4113-9. PubMed ID: 8626749 [TBL] [Abstract][Full Text] [Related]
12. Apoptosis induced in advanced CD8F1-murine mammary tumors by the combination of PALA, MMPR and 6AN precedes tumor regression and is preceded by ATP depletion. Nord LD; Stolfi RL; Alfieri AA; Netto G; Reuter V; Sternberg SS; Colofiore JR; Koutcher JA; Martin DS Cancer Chemother Pharmacol; 1997; 40(5):376-84. PubMed ID: 9272113 [TBL] [Abstract][Full Text] [Related]
13. 6-Aminonicotinamide sensitizes human tumor cell lines to cisplatin. Budihardjo II; Walker DL; Svingen PA; Buckwalter CA; Desnoyers S; Eckdahl S; Shah GM; Poirier GG; Reid JM; Ames MM; Kaufmann SH Clin Cancer Res; 1998 Jan; 4(1):117-30. PubMed ID: 9516960 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of pentose phosphate pathway suppresses acute myelogenous leukemia. Chen Y; Xu Q; Ji D; Wei Y; Chen H; Li T; Wan B; Yuan L; Huang R; Chen G Tumour Biol; 2016 May; 37(5):6027-34. PubMed ID: 26596840 [TBL] [Abstract][Full Text] [Related]
15. In vivo 31P NMR study of the metabolism of murine mammary 16/C adenocarcinoma and its response to chemotherapy, x-radiation, and hyperthermia. Evanochko WT; Ng TC; Lilly MB; Lawson AJ; Corbett TH; Durant JR; Glickson JD Proc Natl Acad Sci U S A; 1983 Jan; 80(2):334-8. PubMed ID: 6572896 [TBL] [Abstract][Full Text] [Related]
17. Effect of 6-aminonicotinamide and other protein synthesis inhibitors on formation of platinum-DNA adducts and cisplatin sensitivity. Budihardjo II; Boerner SA; Eckdahl S; Svingen PA; Rios R; Ames MM; Kaufmann SH Mol Pharmacol; 2000 Mar; 57(3):529-38. PubMed ID: 10692493 [TBL] [Abstract][Full Text] [Related]
18. Changes in 31P nuclear magnetic resonance with tumor growth in radioresistant and radiosensitive tumors. Koutcher JA; Alfieri AA; Barnett DC; Cowburn DC; Kornblith AB; Kim JH Radiat Res; 1990 Mar; 121(3):312-9. PubMed ID: 2315448 [TBL] [Abstract][Full Text] [Related]
19. 31P NMR spectroscopy can predict the optimum interval between fractionated irradiation doses. Murata O; Sakurai H; Mitsuhashi N; Hasegawa M; Yamakawa M; Kurosaki H; Hayakawa K; Niibe H Anticancer Res; 1998; 18(6A):4297-301. PubMed ID: 9891481 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of pentose cycle of A549 cells by 6-aminonicotinamide: consequences for aerobic and hypoxic radiation response and for radiosensitizer action. Varnes ME NCI Monogr; 1988; (6):199-203. PubMed ID: 2965307 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]